“Bad Luck” in Cancer Diagnosis, Lifestyle Guidelines, Pfizer’s Ibrance and More…

Here are a few highlights of cancer research news that have recently caught my attention:

  • Developing cancer may be simply due to “bad luck”, according to a recently published article in Science.
  • Scientists have started clinical trials to test drugs for a gene mutation linked to multiple cancers. More on these trials can be found in journal Cancer Discovery.
  • Lifestyle guidelines may reduce certain cancer risks and overall mortality. For more, please refer to this article in the American Journal of Clinical Nutrition.
  • Stereotactic body radiation therapy plus chemotherapy improves survival rates of stage 4 lung cancer patients according to study at UT Southwestern Medical Center published in the Journal of Clinical Oncology.
  • Pfizer’s Ibrance, new cancer drug type to treat advanced breast cancer, may get early approval.
  • According to the latest annual report from the American Cancer Society, death rates from cancer continue to drop in the US.

.Please feel free to contact Marisol Hernandez to share any comments.